Submitted by Anonymous (not verified) on 26 April 2024 - 14:39
Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 15, Status: Authorised